Sarana Meditama (Indonesia) Performance
| SAME Stock | IDR 282.00 2.00 0.71% |
On a scale of 0 to 100, Sarana Meditama holds a performance score of 5. The entity has a beta of 0.94, which indicates possible diversification benefits within a given portfolio. Sarana Meditama returns are very sensitive to returns on the market. As the market goes up or down, Sarana Meditama is expected to follow. Please check Sarana Meditama's sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to make a quick decision on whether Sarana Meditama's existing price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sarana Meditama Metropolitan are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Sarana Meditama disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 50.4 B | |
| Total Cashflows From Investing Activities | -2.2 T |
Sarana |
Sarana Meditama Relative Risk vs. Return Landscape
If you would invest 25,000 in Sarana Meditama Metropolitan on November 29, 2024 and sell it today you would earn a total of 3,200 from holding Sarana Meditama Metropolitan or generate 12.8% return on investment over 90 days. Sarana Meditama Metropolitan is generating 0.2802% of daily returns and assumes 3.8564% volatility on return distribution over the 90 days horizon. Simply put, 34% of stocks are less volatile than Sarana, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sarana Meditama Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sarana Meditama's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sarana Meditama Metropolitan, and traders can use it to determine the average amount a Sarana Meditama's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0727
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SAME | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.86 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Sarana Meditama is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sarana Meditama by adding it to a well-diversified portfolio.
Sarana Meditama Fundamentals Growth
Sarana Stock prices reflect investors' perceptions of the future prospects and financial health of Sarana Meditama, and Sarana Meditama fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sarana Stock performance.
| Return On Equity | -0.0035 | |||
| Return On Asset | 0.0015 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 5.14 T | |||
| Shares Outstanding | 17.13 B | |||
| Price To Earning | 177.12 X | |||
| Price To Book | 1.32 X | |||
| Price To Sales | 3.87 X | |||
| Revenue | 1.27 T | |||
| EBITDA | 259.08 B | |||
| Cash And Equivalents | 470 B | |||
| Cash Per Share | 21.36 X | |||
| Total Debt | 20.94 B | |||
| Debt To Equity | 75.20 % | |||
| Book Value Per Share | 208.00 X | |||
| Cash Flow From Operations | 253.74 B | |||
| Earnings Per Share | 1.88 X | |||
| Total Asset | 4.95 T | |||
About Sarana Meditama Performance
By examining Sarana Meditama's fundamental ratios, stakeholders can obtain critical insights into Sarana Meditama's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Sarana Meditama is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
PT Sarana Meditama Metropolitan Tbk, together with its subsidiaries, engages in the management of hospitals in Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Omni Health Care. Sarana Meditama is traded on Jakarta Stock Exchange in Indonesia.Things to note about Sarana Meditama Metr performance evaluation
Checking the ongoing alerts about Sarana Meditama for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sarana Meditama Metr help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sarana Meditama Metr had very high historical volatility over the last 90 days | |
| Sarana Meditama Metr has accumulated 20.94 Billion in debt which can lead to volatile earnings | |
| About 76.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Sarana Meditama's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sarana Meditama's stock is overvalued or undervalued compared to its peers.
- Examining Sarana Meditama's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sarana Meditama's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sarana Meditama's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sarana Meditama's stock. These opinions can provide insight into Sarana Meditama's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Sarana Stock
Sarana Meditama financial ratios help investors to determine whether Sarana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sarana with respect to the benefits of owning Sarana Meditama security.